Hemostemix Granted Trademark "KNOW YOUR HEALTH" in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42

Executive Summary

• The Japanese Patent Office, via the WIPO Madrid System, granted Hemostemix Inc. registration of its “KNOW YOUR HEALTH” trademark (International Registration No. 1744775) covering Classes 1, 5 and 42.
• The registration secures Hemostemix’s brand rights in Japan for stem‑cell preparations, pharmaceutical compositions, and related scientific/clinical services, reinforcing the company’s global IP portfolio.
• Management highlights the strategic significance of the trademark for current and future clinical programs, licensing opportunities, and expansion of the ACP‑01 (VesCell™) platform in Asia.

Key Details

• Registration Number: International Registration No. 1744775
• Mark: KNOW YOUR HEALTH
• Classes Covered:
• Class 1 – Chemicals & reagents for scientific/medical research, including stem‑cell preparations for regenerative medicine.
• Class 5 – Pharmaceutical & biological preparations, e.g., autologous stem‑cell compositions for peripheral vascular disease, chronic limb threatening ischemia, various cardiomyopathies, heart disease, COPD, pulmonary hypertension, etc.
• Class 42 – Scientific, clinical and technological services in regenerative medicine, including design, R&D of cell‑based therapies, diagnostics and personalized health data platforms.
• Issuing Authority: Japanese Patent Office (via WIPO Madrid System)

Strategic Significance

• Aligns with Hemostemix’s existing “right‑to‑try” and special access programs for ACP‑01 in multiple jurisdictions, including Japan.
• Expands global IP protection into one of the world’s leading medical‑research markets, supporting licensing, co‑development and commercialization activities.
• Enhances brand consistency across therapeutic areas covered by Hemostemix’s pipeline (angiogenesis, cardiac & pulmonary ischemic diseases).

Notable Quotes

“We are honoured that Japan has granted the ‘Know Your Health’ trademark across the full spectrum of our business—from stem‑cell preparations and therapeutics to our diagnostic and research platforms. This registration validates our expanding global footprint and reflects our commitment to helping patients understand and improve their vascular, cardiac, and neurological health through autologous stem‑cell therapy.” – Thomas Smeenk, President, CEO & Co‑Founder

Materiality Assessment: Material – Positive (the trademark grant materially strengthens Hemostemix’s IP position in a key market, supporting future commercial and partnership activities).